Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden · Delayed Price · Currency is SEK 0.0060
+0.0004 (7.14%)
At close: Mar 4, 2026
Lipigon Pharmaceuticals AB Employees
Lipigon Pharmaceuticals AB had 7 employees as of December 31, 2024. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
188.14K SEK
Profits / Employee
-5.14M SEK
Market Cap
3.64M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 7 | 1 | 16.67% |
| Dec 31, 2023 | 6 | -1 | -14.29% |
| Dec 31, 2022 | 7 | 0 | - |
| Mar 31, 2022 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 7 | 1 | 16.67% |
| Sep 30, 2021 | 6 | 0 | - |
| Jun 30, 2021 | 6 | - | - |
| Mar 31, 2021 | 6 | - | - |
| Dec 31, 2020 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ExpreS2ion Biotech Holding AB | 20 |
| Nanologica AB | 19 |
| AcouSort AB | 16 |
| 2cureX AB | 14 |
| Guard Therapeutics International AB | 12 |
| Fluicell AB | 11 |
| NanoEcho AB | 6 |
| Novakand Pharma AB | 5 |